Download PDF
Erfahrungsheilkunde 2014; 63(6): 347-352
DOI: 10.1055/s-0034-1395801
Praxis
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Erfolgreiche Differenzialtherapie in der komplementären Praxis bei Autoimmunität

Praktisches Vorgehen mit einem Fall aus der Praxis
Stephan Wey
Further Information

Publication History

Publication Date:
16 December 2014 (online)

   Permissions and Reprints

Zusammenfassung

Autoimmune Erkrankungen zählen zu den ätiologisch oft unklaren Krankheiten. Die konventionelle Medizin arbeitet gerade auf diesem Gebiet überwiegend symptomatisch und immunsuppressiv. Dabei werden diagnostisch und therapeutisch viele Chancen verschenkt. Der Beitrag zeigt, wie mit einer konsequenten komplementären Diagnostik und Therapie eine immunsuppressive Behandlung bei einer erst 18-jährigen Patientin vermieden werden konnte, die an einer ätiologisch unklaren „undifferenzierten Kollagenose“ erkrankt war.

Abstract

Autoimmune diseases belong to those diseases where the etiology often is unclear. Especially in this field, conventional medicine mainly deals with the symptoms and uses an immunosuppressive treatment. With this approach, many chances with respect to diagnosis and therapy are missed. The article shows, how it was possible to avoid an immunosuppressive treatment in the case of an 18 years old female patient suffering from an “undifferentiated collagenosis” with an unclear etiology by using a consequent complementary diagnostics and therapy.

Schlüsselwörter

Ernährung - Orthomolekulare Medizin - Kollagenose - Weihrauch - Vitamin D - Histamin

Keywords

Nutrition - orthomolecular medicine - connective tissue disease - boswellia - vitamin d - histamine
 

  • Literatur

  • 1 Colin EM, Asmawidjaja PS, van Hamburg JP et al. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis & Rheumatism 2010; 62: 132-142
    CrossrefPubMedGoogle Scholar
  • 2 Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009; 34S: 265-277
    PubMedGoogle Scholar
  • 3 Merlino LA, Curtis J, Mikuls TR et al. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis & Rheumatism 2004; 50: 72-77
    CrossrefPubMedGoogle Scholar
  • 4 Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142
    CrossrefPubMedGoogle Scholar
  • 5 Vieira VM, Hart JE, Webster TF et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the nurses’ health study. Environ Health Perspect 2010; 118: 957-961
    CrossrefPubMedGoogle Scholar
  • 6 Amital H, Szekanecz Z, Szücs G et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis 2010; 69: 1155-1157
    CrossrefPubMedGoogle Scholar
  • 7 Lange U, Teichmann J, Strunk J et al. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 2005; 16: 1999-2004
    CrossrefPubMedGoogle Scholar
  • 8 Wepner F, Scheuera R, Schuetz-Wiesera B et al. Effects of vitamin D on patients with fibromyalgia syndrome: A randomized placebo-controlled trial. Pain 2014; 155: 261-268
    CrossrefPubMedGoogle Scholar
  • 9 Turner MK, Hooten WM, Schmidt JE et al. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med 2008; 9: 979-984
    CrossrefPubMedGoogle Scholar
  • 10 Sabbagh Z, Markland J, Vatanparast H. Vitamin D status is associated with disease activity among rheumatology outpatients. Nutrients 2013; 5: 2268-2275
    CrossrefPubMedGoogle Scholar
  • 11 Bayer W. Antientzündliche Wirkungen von Omega-3-Fettsäuren. Ernährung und Medizin 2010; 25: 15-19
    PubMedGoogle Scholar
  • 12 Wall R, Ross RP, Fitzgerald GF et al. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010; 68: 280-289
    CrossrefPubMedGoogle Scholar
  • 13 Volker D, Fitzgerald P, Major G et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 2000; 27: 2343-2346
    PubMedGoogle Scholar
  • 14 Adam O, Beringer C, Kless T et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatology International 2003; 23: 27-36
    PubMedGoogle Scholar
  • 15 Mahajan A, Tandon VR. Antioxidants and rheumatoid arthritis. J Indian Rheumatol Assoc 2004; 12: 139-42
    PubMedGoogle Scholar
  • 16 Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004; 6: 265-78
    CrossrefPubMedGoogle Scholar
  • 17 Adam O, Fasse S, Ditrich O. Ernährung bei rheumatischen Erkrankungen. Zeitschrift für Rheumatologie 2009; 68: 549-558
    CrossrefPubMedGoogle Scholar
  • 18 Youn HS, Lim HJ, Choi YJ et al. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists. Int Immunopharmacol 2008; 8: 495-501
    CrossrefPubMedGoogle Scholar
  • 19 Ströhle A, Wolters M, Hahn A. Rheumatoide Arthritis − Bedeutung von Antioxidanzien und anderen Mikronährstoffen. DAZ 2005; 24: 145-
    PubMedGoogle Scholar
  • 20 Honkanen V, Konttinen YT, Sorsa T et al. Serum zinc, copper and selenium in rheumatoid arthritis. J Trace Elem Electrolyte Health Dis 1991; 5: 261-263
    PubMedGoogle Scholar
  • 21 O’Dell JR, Lemley-Gillepies S, Palmer WR et al. Serum selenium in rheumatoid arthritis. Sem Arth Rheum 1991; 20: 305-318
    CrossrefPubMedGoogle Scholar
  • 22 Peretz A, Siderova V, Nève J. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand J Rheumatol 2001; 30: 208-212
    CrossrefPubMedGoogle Scholar
  • 23 Tarp U. Selenium and the selenium-dependent glutathione peroxidase in rheumatoid arthritis. Dan Med Bull 1994; 41: 264-274
    PubMedGoogle Scholar
  • 24 Ryan-Harshman M, Aldoori W. The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Can J Diet Pract Res 1990; 66: 98-102
    PubMedGoogle Scholar
  • 25 Heinle K, Adam A, Gradl M et al. Selenkonzentration in Erythrozyten. Klinische und laborchemische Entzündungszeichen bei Patienten mit rheumatoider Arthritis unter Supplementierung mit Selen. Med Klinik 1997; 92: 29-31
    PubMedGoogle Scholar
  • 26 Bao S, Liu MJ, Lee B et al. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappa B. Am J Physiol Lung Cell Mol Physiol 2010; 298: L744-L754
    CrossrefPubMedGoogle Scholar
  • 27 Cerhan JR, Saag KG, Merlino LA et al. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003; 157: 345-354
    CrossrefPubMedGoogle Scholar
  • 28 Zoli A, Altomonte L, Caricchio R et al. Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin Rheumatol 1998; 17: 378-82
    CrossrefPubMedGoogle Scholar
  • 29 Wanchu A, Sud A, Bambery P et al. Plasma and peripheral blood mononuclear cells levels of Zn and Cu among Indian patients with RA. Ann Rheum Dis 2002; 61: 88-
    CrossrefPubMedGoogle Scholar
  • 30 Mazur A, Maier JAM, Rock E et al. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56
    CrossrefPubMedGoogle Scholar
  • 31 Kim DJ, Xun P, Liu K et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010; 33: 2604-2610
    CrossrefPubMedGoogle Scholar
  • 32 Nielsen FH, Johnson LK, Zeng H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res 2010; 23: 158-168
    PubMedGoogle Scholar
  • 33 Tomić-Lucić AP, Pantović SB, Rosić GL et al. Histamine index and clinical expression of rheumatoid arthritis activity. Vojnosanit Pregl 2010; 67: 286-290
    CrossrefPubMedGoogle Scholar
  • 34 Nent E, Frommholz D, Gajda M et al. Histamine 4 receptor plays an important role in auto-antibody-induced arthritis. Int Immunol 2013; 25: 437-443
    CrossrefPubMedGoogle Scholar
  • 35 Cowden JM, Yu F, Banie H et al. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Annals of the rheumatic diseases 2014; 73: 600-608
    PubMedGoogle Scholar
  • 36 Zirbel R. Weihrauch-Harz: Einsatz in der Integrativen Medizin. OM & Ernährung 2011; 136: 2-6
    PubMedGoogle Scholar
  • 37 Von Keudell C, Letzel H, Koepke W. Klinische Wirksamkeit des Weihrauchpräparates H15 bei rheumatoider Arthritis: Ein neues Therapieprinzip durch spezifische 5-Lipoxygenase-Inhibition. Z Rheumatol 1994; 53: 36-
    PubMedGoogle Scholar
  • 38 Sander O, Herborn G, Rau R. Ist H15 (Harzextrakt von Boswellia serrata, „Weihrauch“), eine sinnvolle Ergänzung zur etablierten medikamentösen Therapie der chronischen Polyarthritis? − Ergebnisse einer doppelblinden Pilotstudie. Z Rheumatol 1998; 57: 11-16
    CrossrefPubMedGoogle Scholar
  • 39 Kimmatkar N, Thawani V, Hingorani L et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee − A randomized double blind placebo controlled trial. Phytomedicine 2003; 10: 3-7
    CrossrefPubMedGoogle Scholar
  • 40 Sontakke S, Thawani V, Pimpalkhute S et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian Journal of Pharmacology 2007; 39: 27-
    CrossrefPubMedGoogle Scholar
  • 41 Singh RP, Agarwal R. Prostate cancer chemoprevention by silibinin: Bench to bedside. Carcinogenesis 2006; 45: 436-442
    CrossrefPubMedGoogle Scholar
  • 42 Hajiaghamohammadi AA, Ziaee A, Oveisi S et al. Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: A randomized controlled pilot study. Hepat Mon 2012; 12: e6099-
    PubMedGoogle Scholar
  • 43 Solhi H, Ghahremani R, Kazemifar AM et al. Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial. Caspian J Intern Med 2014; 5: 9-12
    PubMedGoogle Scholar